Nuvation Bio NUVB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $143.05M+1,206% | $62.9M+699% | $26.75M+1,137% | $14.36M+900% | $10.96M— | ||
| $125.55M+13.2% | $115.11M+16.1% | $110.11M+29.3% | $108.99M+43.4% | $110.88M+69.7% | ||
| $154.48M+58.8% | $151.56M+119% | $137.37M+183% | $119.6M+225% | $97.27M+245% | ||
| $295.32M-54.0% | $278.06M-53.7% | $256.65M-54.1% | $237.76M-55.8% | $642.39M+587% | ||
| $20.34M+5,048% | $13.68M+3,912% | $7.1M+2,717% | $684K+418% | $395K— | ||
| —— | —— | $15.49M-43.1% | $21.74M-19.6% | $25.05M+1.7% | ||
| -$145.99M+75.9% | -$204.63M+64.0% | -$217.48M+59.1% | -$202.9M+60.3% | -$606.38M-781% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$145.99M+75.9% | -$204.63M+64.0% | -$217.48M+59.1% | -$202.9M+60.3% | -$606.38M-781% | ||
| -102.1%+5,432pp | -325.3%+6,888pp | -813.1%+23,807pp | -1,413.4%+34,177pp | -5,534.2%— | ||
| -$148.21M+76.5% | -$211.33M+64.3% | -$231.55M+58.6% | -$223.59M+58.4% | -$630.5M-576% | ||
| -103.6%+5,651pp | -336%+7,183pp | -865.7%+24,990pp | -1,557.6%+35,888pp | -5,754.3%— | ||
| -$150.18M+76.2% | -$213.06M+64.0% | -$232.97M+58.4% | -$224.64M+58.2% | -$631.43M-575% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Nuvation Bio's revenue?
- Nuvation Bio (NUVB) generated $143.0M in revenue over the trailing twelve months, up 1205.5% year over year.
- Is Nuvation Bio profitable?
- Nuvation Bio is not currently profitable: it reported a net loss of $146.0M over the trailing twelve months, a -102.1% net margin.
- What are Nuvation Bio's profit margins?
- Gross margin is 54.3% and operating margin is -105.0%, with a -102.1% net margin.
- What is Nuvation Bio's earnings per share?
- Nuvation Bio's diluted EPS over the trailing twelve months is $-0.43.
- Where does Nuvation Bio's income statement data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
